Claire S. Traylor, Jasmine D. Johnson, MD, Mary C. Kimmel, MD y Tracy A. Manuck. Esta revisión analiza el impacto del estrés en el embarazo y el uso de terapias no farmacológica
Aurora James-Palmer, Ellen Z. Anderson, Lori Zucker , Yana Kofman, y Jean-Francois Daneault. La salud mental de los jóvenes es un problema de salud pública debido al aumento de c
Diogo Amorim, Jose Amado, Irma Brito, Sonia M Fiuza, Nicole Amorim, Cristina Costeira, Jorge Machado. Complemento Ther Clin Pract. Mayo 2018; 31:31-37. Los trastornos de ansiedad s
Ali Khaleghi PhD, Gila Pirzad Jahromi PhD, Hadi Zarafshan PhD, Seyed-Ali Mostafavi PhD, Mohammad Reza Mohammadi MD En esta revisión sistemática y metaanálisis, se examinaron los
Jamilian H, Solhi H, Jamilian M. Randomized, Placebo-Controlled Clinical Trial of Omega-3 as Supplemental Treatment in Schizophrenia. Glob J Health Sci. 2014 Sep;6(7). Pawełczyk T
Jamilian H, Solhi H, Jamilian M. Randomized, Placebo-Controlled Clinical Trial of Omega-3 as Supplemental Treatment in Schizophrenia. Glob J Health Sci. 2014 Sep;6(7). Pawełczyk T
Mark Cropley, Adrian P. Banks, Julia Boyle. The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms. Phytother. 2015. 29: 1934–1939
Jamilian H, Solhi H, Jamilian M. Randomized, Placebo-Controlled Clinical Trial of Omega-3 as Supplemental Treatment in Schizophrenia. Glob J Health Sci. 2014 Sep;6(7). Pawełczyk T
Daphne van Diermen 1 , Andrew Marston, Juan Bravo, Marianne Reist, Pierre-Alain Carrupt, Kurt Hostettmann. Monoamine oxidase inhibition by Rhodiola rosea L. roots. J Ethnopharmacol
Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders. Arch Gen Psychiatry.